# Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis

> **NCT07113574** · PHASE2,PHASE3 · COMPLETED · sponsor: **Karl Landsteiner Insitute for Nephrology and Haemato-Oncology** · enrollment: 12 (actual)

## Conditions studied

- Peritoneal Dialysis Associated Peritonitis
- Peritoneal Dialysis (PD)
- Peritoneal Dialysis
- Peritoneal Dialysis, Continuous Ambulatory
- Meropenem
- Aztreonam
- Antibacterial Agents
- Intraperitoneal Antibiotics
- Kidney Failure, Chronic
- Anti-Bacterial Agents
- Drug Therapy

## Interventions

- **DRUG:** Meropenem 1000 mg
- **DRUG:** Aztreonam 2000 mg
- **OTHER:** automated peritoneal dialysis with following long time dwell
- **DIAGNOSTIC_TEST:** Sampling

## Key facts

- **NCT ID:** NCT07113574
- **Lead sponsor:** Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2022-07-24
- **Final completion:** 2022-07-24
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07113574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07113574, "Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07113574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*